Fewer drugs approved, more money spent – Where’s the beef?
Posted in Archive
| Tagged Biologics / Biotechnology, Biomarkers, Business, Clinical trials, Drug development, Drug discovery, Drug targets, Genetics / genomes, Genetics / genomics, Genomics, High Content Screening, Lead discovery, Molecular medicine, Oncology, Preclinical, Regulatory, Sequencing, System biology, Systems biology, Theranostics, Therapeutics
